Zobrazeno 1 - 10
of 249
pro vyhledávání: '"Piscitello, D."'
Autor:
Pilié PG; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Giuliani V; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang WL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., McGrail DJ; Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, Ohio., Bristow CA; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Ngoi NYL; Department of Investigational Cancer Therapeutics (Phase I Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kyewalabye K; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wani KM; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Le H; Department of Investigational Cancer Therapeutics (Phase I Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Campbell E; Department of Investigational Cancer Therapeutics (Phase I Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sanchez NS; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yang D; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gheeya JS; The University of Texas Health Science Center at Houston, Houston, Texas., Goswamy RV; The University of Texas Health Science Center at Houston, Houston, Texas., Holla V; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Shaw KR; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Meric-Bernstam F; Department of Investigational Cancer Therapeutics (Phase I Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Liu CY; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Ma X; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Feng N; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Machado AA; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Bardenhagen JP; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas., Vellano CP; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Marszalek JR; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Rajendra E; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Piscitello D; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Johnson TI; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Likhatcheva M; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Elinati E; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Majithiya J; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Neves J; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Grinkevich V; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Ranzani M; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Luzarraga MR; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Boursier M; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Armstrong L; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Geo L; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Lillo G; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Tse WY; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Lazar AJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Genomic Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kopetz SE; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Geck Do MK; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lively S; ChemPartner Corporation, San Francisco, California., Johnson MG; ChemPartner Corporation, San Francisco, California., Robinson HMR; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Smith GCM; Artios Pharma, the Glenn Berge Building, Babraham Research Campus, Cambridge, United Kingdom., Carroll CL; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas., Di Francesco ME; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jones P; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas., Heffernan TP; TRACTION (Translational Research to Advance Therapeutics and Innovation in Oncology), The University of Texas MD Anderson Cancer Center, Houston, Texas., Yap TA; Department of Investigational Cancer Therapeutics (Phase I Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 May 15; Vol. 30 (10), pp. 2121-2139.
Autor:
Rodriguez-Berriguete G; Department of Oncology, University of Oxford, Oxford, United Kingdom., Ranzani M; Artios Pharma, Babraham Research Campus, Cambridge, United Kingdom., Prevo R; Department of Oncology, University of Oxford, Oxford, United Kingdom., Puliyadi R; Department of Oncology, University of Oxford, Oxford, United Kingdom., Machado N; Department of Oncology, University of Oxford, Oxford, United Kingdom., Bolland HR; Department of Oncology, University of Oxford, Oxford, United Kingdom., Millar V; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Ebner D; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Boursier M; Artios Pharma, Babraham Research Campus, Cambridge, United Kingdom., Cerutti A; Artios Pharma, Babraham Research Campus, Cambridge, United Kingdom., Cicconi A; Artios Pharma, Babraham Research Campus, Cambridge, United Kingdom., Galbiati A; Artios Pharma, Babraham Research Campus, Cambridge, United Kingdom., Grande D; Artios Pharma, Babraham Research Campus, Cambridge, United Kingdom., Grinkevich V; Artios Pharma, Babraham Research Campus, Cambridge, United Kingdom., Majithiya JB; Artios Pharma, Babraham Research Campus, Cambridge, United Kingdom., Piscitello D; Artios Pharma, Babraham Research Campus, Cambridge, United Kingdom., Rajendra E; Artios Pharma, Babraham Research Campus, Cambridge, United Kingdom., Stockley ML; Artios Pharma, Babraham Research Campus, Cambridge, United Kingdom., Boulton SJ; Artios Pharma, Babraham Research Campus, Cambridge, United Kingdom.; The Francis Crick Institute, London, United Kingdom., Hammond EM; Department of Oncology, University of Oxford, Oxford, United Kingdom., Heald RA; Artios Pharma, Babraham Research Campus, Cambridge, United Kingdom., Smith GCM; Artios Pharma, Babraham Research Campus, Cambridge, United Kingdom., Robinson HMR; Artios Pharma, Babraham Research Campus, Cambridge, United Kingdom., Higgins GS; Department of Oncology, University of Oxford, Oxford, United Kingdom.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Apr 14; Vol. 29 (8), pp. 1631-1642.
Autor:
Ciuna, I., Guarnaccia, M., Ginestra, E., Agodi, A., Piscitello, D., Spitaleri, S., Marcì, G., Paravizzini, G., Trapani, C., Travali, S., Saravo, L.
Publikováno v:
In International Congress Series April 2006 1288:343-345
Autor:
Ginestra, E., Ciuna, I., Guarnaccia, M., Agodi, A., Piscitello, D., Trapani, C., Marcí, G., Paravizzini, G., Romano, C., Travali, S., Saravo, L.
Publikováno v:
In International Congress Series April 2006 1288:231-233
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Forensic Science International: Genetics Supplement Series 2008 1(1):444-445
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Calderon-Aparicio, Ali1 (AUTHOR) ali.calderonaparicio@jefferson.edu, He, Jun2 (AUTHOR) jun.he@jefferson.edu, Simone, Nicole L.1 (AUTHOR) nicole.simone@jefferson.edu
Publikováno v:
International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 19, p10461. 11p.
Autor:
Tassone, Giusy1 (AUTHOR), Maramai, Samuele1 (AUTHOR) maramai@unisi.it, Paolino, Marco1 (AUTHOR), Lamponi, Stefania1 (AUTHOR), Poggialini, Federica1 (AUTHOR), Dreassi, Elena1 (AUTHOR), Petricci, Elena1 (AUTHOR), Alcaro, Stefano2,3 (AUTHOR), Pozzi, Cecilia1,4 (AUTHOR) cecilia.pozzi@unisi.it, Romeo, Isabella2,3 (AUTHOR)
Publikováno v:
Scientific Reports. 9/28/2024, Vol. 14 Issue 1, p1-18. 18p.